Several schemes managed by DSP Asset Managers have divested a substantial portion of their holdings in Cohance Lifesciences Limited. A total of 28,99,996 shares were sold on August 07, 2026, resulting in a decrease of the acquirer’s total shareholding to 3.53%. This sale represents a change of more than 2% from the previously disclosed holding.
DSP Schemes Reduce Cohance Lifesciences Stake
DSP Trustee Private Limited, acting as the trustee for various DSP Mutual Fund (DSPMF) and DSP Alternative Investment Fund (DSPAIF) schemes, has reported a significant sale of shares in Cohance Lifesciences Limited. The transaction, which took place on August 07, 2026, involved the disposal of 28,99,996 shares by multiple DSPMF schemes, including DSP Aggressive Hybrid Fund, DSP Equity Savings Fund, and others.
Holding Changes Below Key Threshold
This sale has led to a reduction in the overall shareholding of the acquirer and its persons acting in concert to 3.53% of Cohance Lifesciences’ total paid-up capital. This represents a decrease exceeding 2% compared to the holding previously disclosed in accordance with SEBI Regulations. Prior to this sale, the total holding before the sale consideration was 4.29%.
Transaction Details
The shares were sold via the Open Market. The total diluted share/voting capital of Cohance Lifesciences Limited after the said sale remains at 38,25,97,330 shares. The reporting of this change is in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as the change in shareholding exceeded the two percent threshold.
Source: BSE
